Inactive Instrument

Company Vifor Pharma Berne S.E.

Equities

Pharmaceuticals

End-of-day quote Berne S.E.
- CHF 0.00% Intraday chart for Vifor Pharma

Business Summary

Vifor Pharma AG, formerly known as Galenica AG, is a Switzerland-based company engaged in the healthcare market. The Company operates through a single pharmaceutical segment. It develops, manufactures and markets pharmaceutical products, specializing in therapies for iron deficiency, nephrology and cardio-renal diseases. The Company's portfolio of iron deficiency treatments includes intravenous products, Ferinject and Venofer, and oral product, Maltofer, among others. Its portfolio of renal pharmaceuticals includes products for anaemia management, such as Mircera, mineral and bone management, such as Velphoro, Rayaldee and Osvaren, and cardio-renal management, such as patiromer (in the United States sold under the brand Veltassa). The Company also conducts research in the area of infectious and rare diseases, partnering with other biopharmaceutical companies. The Company has production sites in Switzerland and Portugal as well as a network of affiliates and partners around the world.

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 65,000,000 1,042,293 ( 1.604 %) 108,662 ( 0.1672 %) 1.604 %

Company contact information

Vifor Pharma AG

Rechenstrasse 37

9014, St. Gallen

+41 58 851 80 00

http://www.viforpharma.com/
address Vifor Pharma

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Distributors